Literature DB >> 23378531

Mitochondria and the lectin pathway of complement.

Christel R Brinkmann1, Lisbeth Jensen, Frederik Dagnæs-Hansen, Ida E Holm, Yuichi Endo, Teizo Fujita, Steffen Thiel, Jens C Jensenius, Søren E Degn.   

Abstract

Mitochondria, the powerhouses of our cells, are remnants of a eubacterial endosymbiont. Notwithstanding the evolutionary time that has passed since the initial endosymbiotic event, mitochondria have retained many hallmarks of their eubacterial origin. Recent studies have indicated that during perturbations of normal homeostasis, such as following acute trauma leading to massive necrosis and release of mitochondria, the immune system might mistake symbiont for enemy and initiate an inappropriate immune response. The innate immune system is the first line of defense against invading microbial pathogens, and as such is the primary suspect in the recognition of mitochondria-derived danger-associated molecular patterns and initiation of an aberrant response. Conversely, innate immune mechanisms are also central to noninflammatory clearance of innocuous agents. Here we investigated the role of a central humoral component of innate immunity, the lectin pathway of complement, in recognition of mitochondria in vitro and in vivo. We found that the soluble pattern recognition molecules, mannan-binding lectin (MBL), L-ficolin, and M-ficolin, were able to recognize mitochondria. Furthermore, MBL in complex with MBL-associated serine protease 2 (MASP-2) was able to activate the lectin pathway and deposit C4 onto mitochondria, suggesting that these molecules are involved either in homeostatic clearance of mitochondria or in induction of untoward inflammatory reactions. We found that following mitochondrial challenge, C3 was consumed in vivo in the absence of overt inflammation, indicating a potential role of complement in noninflammatory clearance of mitochondria. Thus, we report here the first indication of involvement of the lectin pathway in mitochondrial immune handling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378531      PMCID: PMC3605621          DOI: 10.1074/jbc.M112.430249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  L-ficolin is a pattern recognition molecule specific for acetyl groups.

Authors:  Anders Krarup; Steffen Thiel; Annette Hansen; Teizo Fujita; Jens C Jensenius
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

Review 2.  Role of complement and complement regulators in the removal of apoptotic cells.

Authors:  L A Trouw; A M Blom; P Gasque
Journal:  Mol Immunol       Date:  2007-10-24       Impact factor: 4.407

3.  Structural insights into the innate immune recognition specificities of L- and H-ficolins.

Authors:  Virginie Garlatti; Nicolas Belloy; Lydie Martin; Monique Lacroix; Misao Matsushita; Yuichi Endo; Teizo Fujita; Juan Carlos Fontecilla-Camps; Gérard J Arlaud; Nicole M Thielens; Christine Gaboriaud
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

4.  Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide.

Authors:  S Hirano
Journal:  Am J Physiol       Date:  1996-05

5.  Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.

Authors:  Mikio Kuraya; Zhenping Ming; Xianzhou Liu; Misao Matsushita; Teizo Fujita
Journal:  Immunobiology       Date:  2005       Impact factor: 3.144

6.  Ontogeny of human mannan-binding protein, a lectin of the innate immune system.

Authors:  S Thiel; T Bjerke; D Hansen; L K Poulsen; P O Schiøtz; J C Jensenius
Journal:  Pediatr Allergy Immunol       Date:  1995-02       Impact factor: 6.377

7.  Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.

Authors:  Minoru Takahashi; Daisuke Iwaki; Kazuko Kanno; Yumi Ishida; Jie Xiong; Misao Matsushita; Yuichi Endo; Shigeto Miura; Naoto Ishii; Kazuo Sugamura; Teizo Fujita
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

8.  Injection of isolated mitochondria during early reperfusion for cardioprotection.

Authors:  James D McCully; Douglas B Cowan; Christina A Pacak; Ioannis K Toumpoulis; Haripriya Dayalan; Sidney Levitsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

9.  Purification of native and recombinant cobra venom factor using thiophilic adsorption chromatography.

Authors:  Johanna Kölln; Ingke Braren; Reinhard Bredehorst; Edzard Spillner
Journal:  Protein Pept Lett       Date:  2007       Impact factor: 1.890

Review 10.  The clearance of apoptotic cells by complement.

Authors:  Roelof Flierman; Mohamed R Daha
Journal:  Immunobiology       Date:  2006-12-21       Impact factor: 3.144

View more
  18 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Authors:  Ayman Akil; Qing Zhang; Christen L Mumaw; Nisha Raiker; Jeffrey Yu; Nieves Velez de Mendizabal; Laura S Haneline; Kent A Robertson; Jodi Skiles; Maribel Diaz-Ricart; Enric Carreras; Jamie Renbarger; Samir Hanash; Robert R Bies; Sophie Paczesny
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-11       Impact factor: 5.742

3.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

4.  Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.

Authors:  K Aaron Geno; Brady L Spencer; Moon H Nahm
Journal:  J Immunol Methods       Date:  2015-05-30       Impact factor: 2.303

5.  mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes.

Authors:  Ke Liu; Yingjuan Qian; Yong-Sam Jung; Bin Zhou; Ruibing Cao; Ting Shen; Donghua Shao; Jianchao Wei; Zhiyong Ma; Puyan Chen; Huaimin Zhu; Yafeng Qiu
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

6.  Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

Authors:  Mohammad Abu Zaid; Juan Wu; Cindy Wu; Brent R Logan; Jeffrey Yu; Corey Cutler; Joseph H Antin; Sophie Paczesny; Sung Won Choi
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

7.  Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis.

Authors:  Bhargavi Duvvuri; Al Anoud Baddour; Kevin D Deane; Marie L Feser; J Lee Nelson; M Kristen Demoruelle; Christian Lood
Journal:  J Autoimmun       Date:  2021-03-10       Impact factor: 7.094

Review 8.  Complement and human T cell metabolism: Location, location, location.

Authors:  Erin E West; Natalia Kunz; Claudia Kemper
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 10.983

9.  Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °C.

Authors:  Kimball Aaron Geno; Richard E Kennedy; Patricia Sawyer; Cynthia J Brown; Moon H Nahm
Journal:  PeerJ       Date:  2016-11-17       Impact factor: 2.984

Review 10.  Keeping It All Going-Complement Meets Metabolism.

Authors:  Martin Kolev; Claudia Kemper
Journal:  Front Immunol       Date:  2017-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.